NVDA
NVIDIA
-- 139.240 TSLA
Tesla
-- 432.970 PLTR
Palantir
-- 80.504 RGTI
Rigetti Computing
-- 11.0550 AMD
Advanced Micro Devices
-- 124.740 
Analysts interpret the drug's trial data as a key derisking ...
Analysts interpret the drug's trial data as a key derisking event for Vertex's stock, hinting at a potential blockbuster product. Concerns, however, are expressed over the absence of a placebo in the chronic neuropathic pain trial.
Vertex Stock Jumps on Hope for a Pain-Pill Blockbuster -- Barrons.com
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment